Calendar Sorrento Therapeutics, Inc.

Equities

SRNE

US83587F2020

Market Closed - OTC Markets 01:24:55 27/04/2024 am IST 5-day change 1st Jan Change
0.0137 USD -31.50% Intraday chart for Sorrento Therapeutics, Inc. -31.50% -88.91%

Chart calendar Sorrento Therapeutics, Inc.

3d1d5c5b716.KqxOFVjCa4_M8VFMcpgd3g88h9sSSnYDiYV36osquNs.UPonR2ygHce5o2QoCNRolmVQsaFFfDx62cI02d1AgOkS-gtvFIUq5aOLGA~67e5b7a77f8b834942db6d1fed18515c

Upcoming events on Sorrento Therapeutics, Inc.

No events available

Past events on Sorrento Therapeutics, Inc.

09/03/2023 Q4 2022 Earnings Release (Projected)
15/12/2022 Annual General Meeting
17/11/2022 10:00 pm Investor Meeting - Key Opinion Leader
13/11/2022 American College of Rheumatology Convergence Conference
09/11/2022 08:30 pm Extraordinary Shareholders Meeting
14/09/2022 05:30 pm Morgan Stanley Global Healthcare Conference
15/08/2022 Interim 2022 Earnings Release
06/05/2022 02:35 am American Society of Interventional Pain Physicians Meeting
05/05/2022 Q1 2022 Earnings Release
27/04/2022 07:30 pm B Riley Securities Virtual Neurology & Ophthalmology Conference
23/04/2022 Chinese Society of Clinical Oncology Guideline Conference
07/01/2022 01:20 am Longwood Healthcare Leaders Winter Conference
05/01/2022 03:30 am H.C. Wainwright BioConnect Virtual Conference
02/12/2021 02:00 am Evercore ISI HealthCONx Conference
16/11/2021 01:30 am Annual General Meeting
29/09/2021 10:05 pm Benzinga Healthcare Small Cap Conference - Panel
29/09/2021 09:00 pm Benzinga Healthcare Small Cap Conference
29/09/2021 06:50 pm Cantor Fitzgerald Global Healthcare Conference
13/09/2021 H.C. Wainwright Global Investment Conference
06/08/2021 Interim 2021 Earnings Release

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022
Net sales
Million USD
Released
Forecast
Spread
21,2
17,8
19.22%
31,4
25,2
24.74%
40,0
41,3
-3.1%
52,9
58,1
-8.91%
62,8
65,9
-4.65%
EBITDA
Million USD
Released
Forecast
Spread
-117
-105
-10.86%
-180
-187
3.41%
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-150
-139
-8.32%
-259
-236
-9.79%
-245
-214
-14.42%
-377
-368
-2.62%
-504
-448
-12.68%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-214
-194
-10.1%
-360
-346
-3.78%
-311
-282
-10.22%
-463
-368
-25.79%
-562
-462
-21.59%
Net income
Million USD
Released
Forecast
Spread
-204
-183
-11.18%
-292
-235
-24.22%
-298
-282
-5.71%
-428
-367
-16.57%
-573
-419
-36.74%
EPS
USD
Released
Forecast
Spread
-1,92
-1,73
-10.77%
-2,20
-2,23
1.35%
-1,30
-1,23
-5.69%
-1,45
-1,25
-16%
-1,37
-1,01
-35.64%
Announcement Date15/03/1903/03/2019/02/2111/03/2216/03/23

Quarterly results

Fiscal PeriodDecember 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1
Net sales
Million USD
Released
Forecast
Spread
13,5
17,0
-20.59%
12,1
16,9
-28.63%
13,1
18,3
-28.36%
18,4
21,1
-12.96%
11,5
29,4
-61.04%
17,4
15,5
12.26%
15,6
18,7
-16.43%
16,3
20,0
-18.75%
EBIT
Million USD
Released
Forecast
Spread
-101
-72,1
-39.48%
-90,3
-87,8
-2.76%
-114
-80,8
-41.18%
-107
-78,7
-35.75%
-118
-71,6
-65.23%
-109
-102
-7.83%
-170
-113
-50.29%



Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-167
-70,1
-138.55%
-120
-85,7
-39.7%
-178
-83,3
-113.89%
-38,9
-76,3
48.98%
-221
-69,1
-219.08%
-91,7
-105
12.41%
-210
-111
-90.04%



Net income
Million USD
Released
Forecast
Spread
-167
-70,1
-137.55%
-120
-85,7
-39.73%
-144
-83,3
-73.47%
-40,8
-76,3
46.53%
-219
-69,1
-216.42%
-89,6
-104
13.7%
-224
-69,8
-220.56%



EPS
USD
Released
Forecast
Spread
-0,57
-0,24
-137.5%
-0,40
-0,29
-37.93%
-0,47
-0,27
-74.07%
-0,12
-0,22
45.45%
-0,54
-0,20
-170%
-0,20
-0,26
23.08%
-0,49
-0,15
-226.67%
-0,26
-0,16
-62.5%
Announcement Date06/08/2105/11/2111/03/2205/05/2215/08/2208/11/2216/03/2315/05/23

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SRNE Stock
  4. Calendar Sorrento Therapeutics, Inc.